A woman goes quiet. She might be losing interest. She might be pregnant, grieving a loss she has not told anyone about, in a symptom flare, or simply well. In the data those look identical, and they call for opposite responses. Metis designs engagement systems that account for both readings, the commercial and the human, before a platform decides what to do.
You’ll be taken to a secure page to access the brief.
That gap, between the signal and its meaning, is the work.
Every women's health platform can already see when someone goes quiet. Logging stops, sessions thin out, the check-in goes unanswered. Almost none of them can tell you why, and the response that protects a renewal is frequently the response that damages a relationship.
A model that cannot distinguish disinterest from grief will send the wrong message at the worst possible moment. In this category the wrong message does not just cost you a renewal. It costs you her trust in the product, permanently.
Engagement is a proxy, not an outcome. It is what a platform measures while it cannot yet measure health. Useful, temporary, and easy to mistake for the thing itself.
A disengagement signal is not a churn signal. In women's health the two come apart constantly, and almost no current model separates them. Most teams discover this the expensive way.
Prediction without a defensible response is surveillance with extra steps. If a team cannot say what it will do with a flag, and justify it to the person flagged, the flag is not ready to build.
A model that cannot be explained to the woman it is about will not survive the regulator either. In reproductive health, explainability is not a compliance exercise. It is the design constraint that keeps the product honest.
Design predictive engagement systems that detect early signals of disengagement. And define which signals should never trigger an intervention at all. A woman who stops logging during a miscarriage is not a retention problem. A system that cannot tell the difference will optimize itself into harm.
Map engagement across hormone-driven journeys, from menstrual health to menopause. What healthy participation looks like changes with the physiology, and a single retention curve will mislead you across all of it. A fertility user who succeeds leaves. A perimenopausal user engages in bursts that track her symptoms, not her interest. Designed as one lifecycle, both read as failure.
Build the chain that connects engagement to health outcomes to revenue, then find where it is broken. The middle link is usually the missing one. Most platforms can prove that engagement drives renewal and can prove nothing about whether it drives health, so they optimize the half they can see. That is how a metric comes loose from the thing it was meant to represent.
Metis is the Greek goddess of wisdom, foresight and strategy. Not knowledge that can be written down and handed over, but the kind that reads a situation and adapts to it.
That distinction is the practice. Women's health platforms have to measure people in order to help them, and measurement flattens what it measures. Standard retention playbooks arrive as rules to apply. This work is closer to judgment: strategic intelligence, adaptability and craft, applied so that a platform can measure without flattening.

Carla Moss spent fourteen years in enterprise Customer Success in Silicon Valley, almost all of it with media and streaming companies. At Ooyala she carried an $8M ARR portfolio of strategic accounts. The same names recurred across employers: Disney, DIRECTV, HBO, CBS, Tribune, Hallmark. Enterprise video is a market where a few very large buyers control most of the spend, and she carried the biggest of them.
At Citrix she ranked in the top three nationally for revenue retention. Femtech is built the same way. Deep specialization inside a concentrated vertical is the pattern of the entire career, not a recent decision.
Since 2020 she has worked as a practitioner inside digital health, coaching across femtech platforms, virtual clinics and medical practices, through perimenopause and menopause, fertility and pregnancy, PCOS, metabolic health and autoimmune conditions. She is a National Board-Certified Health and Wellness Coach and a Functional Medicine Certified Health Coach. Her coaching practice, Being Well Aware, is where the practitioner perspective comes from. It is ongoing fieldwork, not a side project.
She has been the coach in the session when a woman quietly gives up on her own health. She has also been the operator watching that same moment arrive as a number on a dashboard. Most teams have someone who can read one of those. Very few have anyone who can read both, and notice when they disagree.
Metis engagements are advisory. They are not coaching, and they are not clinical services. The role is defined in writing at the outset of every engagement.
Carla Moss is a National Board-Certified Health and Wellness Coach and a Functional Medicine Certified Health Coach. Those credentials are the source of the practitioner perspective the practice is built on. They are not a claim to clinical authority, and Metis does not diagnose, interpret medical data, or advise on individual care.
Health information is handled to the standard the certification expects, which follows HIPAA practice regardless of whether a given engagement falls within HIPAA's legal scope. Where an engagement requires access to protected health information, a Business Associate Agreement is executed before work begins.
No engagement produces individually identifiable reproductive or health information for an employer, a payer, or any third party the user has not knowingly consented to. Aggregate reporting that cannot be reidentified is standard practice in employer-purchased benefits and is not at issue.
Engagement scoring is designed so that any score can be shown to the person it describes.
Regulatory scope is confirmed at the start of every engagement, including HIPAA applicability, state health privacy law, and where relevant the EU AI Act. Requirements vary considerably by product and distribution model, and assuming they do not is a common and expensive error.
Metis Labs provides ongoing analysis on femtech retention, women's health, and the role of AI in the future of care. labs.metisfemtech.com
For partnership inquiries or advisory conversations:
METIS FEMTECH